Recombinant Chlamydophila caviae tRNA-specific 2-thiouridylase mnmA (mnmA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during ordering for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a particular tag, please specify it for preferential development.
Synonyms
mnmA; trmU; CCA_00354; tRNA-specific 2-thiouridylase MnmA; EC 2.8.1.13
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-360
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Chlamydophila caviae (strain GPIC)
Target Names
mnmA
Target Protein Sequence
MNKTVVVAMS GGVDSSVVAY LLKTTTPYKV IGLFMKNWEE EDSDGLCSTA KDYEDVERVA GQLDIPYYTV SFAKEYRERV FSRFLREYSK GYTPNPDVLC NREIKFDLLQ RKVRELGGDF LATGHYCRLS SAAEGRHLLR GLDPQKDQSY FLCGTRRESL DNVLFPLGGM TKTKVRAIAE QARLATAQKR DSTGICFIGK RPFKSFLEKF VPNVEGDIVD YDSQKVVGRH EGAHYYTIGQ RRGLDLGGSE KPCYVVGKDM EKNIVYIVRG EDHPLLYQTE LTAKELNWFV SPESITRCSA KVRYRSEDEE CEILHSDEDS EVRVRFSSPV KAITPGQTIA FYDGEKCLGG GVIEVSMTPH
Uniprot No.

Target Background

Function

Function: Catalyzes the 2-thiolation of uridine at the wobble position (U34) of tRNA, resulting in the formation of s2U34.

Database Links
Protein Families
MnmA/TRMU family
Subcellular Location
Cytoplasm.

Q&A

What is C. caviae tRNA-specific 2-thiouridylase mnmA and what is its fundamental role?

C. caviae tRNA-specific 2-thiouridylase mnmA is an enzyme responsible for the 2-thiouridine (s²U) modification at position 34 of specific tRNAs, particularly those for lysine, glutamate, and glutamine. The 2-thiouridine modification is crucial for maintaining the structural stability of tRNA, ensuring proper aminoacylation, and enabling precise and efficient codon recognition during protein translation .

The modification occurs specifically at the wobble position (first anticodon position) of these tRNAs, which helps restrict codon-anticodon wobble during protein synthesis on the ribosome, thus enhancing translational accuracy .

How does C. caviae mnmA compare to mnmA in other bacterial species?

While the specific properties of C. caviae mnmA haven't been as extensively characterized as those in E. coli, comparative analysis reveals several important insights:

FeatureC. caviaeE. coliOther Chlamydial species
Genomic contextPart of 1,009 total ORFsWell-characterizedSimilar conservation across species
tRNA targetsLys, Glu, Gln tRNAsLys, Glu, Gln tRNAsLikely conserved
MechanismLikely similar to E. coliPersulfide or [4Fe-4S] dependentLikely conserved
ConservationPresent across ChlamydiaWell-studiedHigh conservation

C. caviae contains 38 tRNAs in its genome , and as in other bacteria, the mnmA enzyme likely acts specifically on tRNA⁽ᴸʸˢ⁾, tRNA⁽ᴳˡᵘ⁾, and tRNA⁽ᴳˡⁿ⁾. The mechanistic details are likely similar to those described for E. coli mnmA, which involves an adenylated intermediate during the thiolation process .

What experimental methods are commonly used to study mnmA activity?

Several experimental approaches can be employed to study mnmA activity:

  • Mass spectrometry analysis: This technique can detect the presence of 2-thiouridine modifications in tRNA. For example, in research with S. pombe, mcm⁵S²U was detected as the protonated molecule (MH⁺) and the protonated free base (BH₂⁺) with m/z values of 333 and 201, respectively .

  • 2D gel electrophoresis with phosphoprotein staining: While primarily used for phosphoproteomic analysis, this approach can be adapted to study mnmA and its potential post-translational modifications .

  • In vitro reconstitution assays: Using purified recombinant mnmA, specific tRNAs, ATP, and a sulfur donor system to measure the formation of thiouridine.

  • Genetic knockout studies: Creating mnmA-deficient strains to assess phenotypic consequences and changes in tRNA modification profiles.

  • Crystal structure analysis: X-ray diffraction studies have been used to determine the structure of mnmA-tRNA complexes, providing insights into the catalytic mechanism .

What are the current proposed catalytic mechanisms for mnmA-mediated 2-thiouridine formation?

Two distinct mechanisms have been proposed for mnmA-mediated 2-thiouridine formation, with ongoing debate about which one accurately represents the in vivo process:

  • Persulfide-dependent mechanism:

    • Initially, the L-cysteine desulfurase IscS generates a persulfide on a conserved cysteine residue

    • Sulfur is transferred through intermediary proteins (in E. coli: TusA → TusBCD → TusE)

    • MnmA accepts the persulfide sulfur on a conserved Cys199 residue

    • Uridine 34 of the bound tRNA reacts with ATP to form an acyl-adenylated intermediate

    • The terminal sulfur from MnmA-Cys199 persulfide attacks this intermediate to form 2-thiouridine

  • [4Fe-4S] cluster-dependent mechanism:

    • MnmA is proposed to contain a [4Fe-4S] cluster essential for activity

    • The cluster may facilitate electron transfer during the thiolation reaction

    • This mechanism is more recently proposed and remains contentious

    • The [4Fe-4S] cluster could be labile under aerobic conditions, potentially explaining why it wasn't detected in earlier studies

Current evidence hasn't definitively resolved which mechanism operates in vivo. The review by ASM journals notes: "A crystal structure of the natively and anaerobically purified enzyme containing an [4Fe-4S] cluster would help in providing the definitive resolution of mechanism" .

How does the crystal structure of mnmA inform our understanding of its function?

The crystal structure of E. coli mnmA in complex with tRNA-Glu provides crucial insights that likely apply to C. caviae mnmA due to conservation across bacterial species:

  • Conformational changes during catalysis:

    • Upon enzyme activation, an α-helix overhanging the active site restructures into a β-hairpin-containing loop

    • This restructuring packs the flipped-out U34 deeply into the catalytic pocket

    • The conformational change triggers activation of catalytic cysteine residues

  • Active site architecture:

    • The enzyme forms a closed catalytic chamber that prevents solvent access

    • This isolation is crucial for preventing side reactions with the reactive intermediates

    • The adenylated RNA intermediate has been trapped in crystal structures

  • tRNA recognition elements:

    • The structures reveal how mnmA specifically recognizes its three different tRNA substrates (tRNA⁽ᴸʸˢ⁾, tRNA⁽ᴳˡᵘ⁾, and tRNA⁽ᴳˡⁿ⁾)

    • This specificity ensures precise modification at the correct position

The crystal structure of mnmA-tRNA complex at 3.4 Å resolution (PDB ID: 2DET) provides "snapshots of the sequential chemical reactions during RNA sulphuration" , offering valuable insights for researchers working with C. caviae mnmA.

What experimental designs are optimal for investigating mnmA function?

When designing experiments to study C. caviae mnmA function, consider these approaches:

  • Compound optimization experimental design:

    • This approach allows for multiple objectives to be balanced

    • Particularly useful when exploring both screening and mechanistic aspects

    • Can help optimize expression conditions, activity assays, and structural studies simultaneously

  • Quasi-experimental designs:

    • When complete control of variables isn't possible, quasi-experimental designs may be necessary

    • These can help address the "intransigency of the environment" in complex biological systems

  • Genetic manipulation strategies:

    • Knockout studies: Create mnmA-deficient strains to assess phenotypic consequences

    • Complementation experiments: Reintroduce wild-type or mutant mnmA to knockout strains

    • Site-directed mutagenesis: Target conserved cysteines potentially involved in persulfide formation or [4Fe-4S] cluster binding

  • In vitro reconstitution assays:

    • Anaerobic purification to preserve potential [4Fe-4S] clusters

    • Native mass spectrometry to detect the presence of clusters or persulfides

    • Radioactively labeled sulfur incorporation assays

  • Mass spectrometry for tRNA modification analysis:

    • LC-MS/MS approaches to detect and quantify modified nucleosides

    • Comparative analysis between wild-type and mnmA-deficient strains

When interpreting results, researchers should be cautious about relying on a single experimental approach, as noted in the literature: "The analysis of mutant strains often can be used to help clarify a hypothesis, but often not only one pathway is influenced in a mutant strain, but several pathways can also be altered, and therefore the results should be treated with caution" .

Is C. caviae mnmA subject to post-translational modifications?

While specific data on post-translational modifications of C. caviae mnmA is limited, the phosphoproteomic analysis of C. caviae provides context for investigating this question:

  • Phosphoproteomic landscape of C. caviae:

    • Forty-two non-redundant phosphorylated proteins were identified in C. caviae

    • Developmental stage-specific phosphorylation patterns were observed

    • EBs contained threefold more phosphorylated proteins than RBs (34 versus 11)

  • Phosphoprotein distribution by developmental stage:

C. caviae developmental stageEBRB
P-spots (total unique spots)7367
Overlapping P-spots44 (60%)52 (78%)
C. caviae proteins40 (91%)16 (31%)
Non-redundant C. caviae proteins34 (85%)11 (69%)

This developmental stage-specific phosphorylation suggests that protein function may be regulated differently in EBs versus RBs .

  • Potential implications for mnmA:

    • If mnmA is phosphorylated, its activity might be differentially regulated during the developmental cycle

    • Phosphorylation could affect protein-protein interactions, including those with sulfur transfer proteins

    • Stage-specific regulation could coordinate tRNA modification with translation requirements during the EB-RB transition

Researchers studying C. caviae mnmA should consider investigating potential phosphorylation using targeted phosphoproteomic approaches.

What is the impact of mnmA deficiency on bacterial physiology?

The physiological consequences of mnmA deficiency have been studied in various organisms and provide insights relevant to C. caviae research:

  • Translational defects:

    • Absence of s²U modifications leads to increased frameshifting during translation

    • This results in mistranslation and production of aberrant proteins

    • The modified mnm⁵s²UUU is essential for proper interaction with AAA- or AAG-containing codons

  • Impact on related organisms:

    • In T. gondii, knockout of the apicoplast-located tRNA thiouridylase (TgMnmA) demonstrated its importance for the lytic cycle of tachyzoites

    • Loss of TgMnmA led to abnormalities in apicoplast biogenesis and severely disturbed apicoplast genomic transcription

    • Notably, mice survived infection with TgMnmA-KO parasites, suggesting potential as a drug target

  • Viability considerations:

    • In E. coli, mnmA is not essential for viability, though its absence affects growth and stress responses

    • The essentiality in C. caviae has not been definitively established but can be predicted based on its conserved role in translation

Understanding the phenotypic consequences of mnmA deficiency in C. caviae could provide insights into the organism's biology and potentially identify new therapeutic targets for Chlamydia-related diseases.

How can mass spectrometry be optimally used to analyze mnmA-mediated tRNA modifications?

Mass spectrometry provides powerful tools for analyzing tRNA modifications. For researchers working with C. caviae mnmA, these approaches are particularly valuable:

  • LC-MS/MS analysis of nucleosides:

    • Total tRNA is enzymatically digested to nucleosides

    • Modified nucleosides are separated by HPLC and detected by MS/MS

    • 2-thiouridine can be detected based on characteristic mass shifts

    • In studies with S. pombe, mcm⁵S²U was detected with m/z values of 333 (MH⁺) and 201 (BH₂⁺)

  • Comparative analysis between wild-type and mnmA-deficient strains:

    • When mnmA is deleted, mcm⁵S²U is absent and replaced by mcm⁵U

    • This can be observed through the appearance of signals with m/z values of 317 (MH⁺) and 185 (BH₂⁺)

  • Quantitative approaches:

    • Isotope-labeled internal standards can be used for absolute quantification

    • Relative quantification between samples provides insights into modification efficiency

    • Multiple reaction monitoring (MRM) increases sensitivity for targeted analysis

  • Sample preparation considerations:

    • Maintain RNA integrity during extraction to prevent degradation

    • Consider enrichment of specific tRNA species before analysis

    • Use appropriate controls to validate identification of modified nucleosides

What challenges exist in expressing and purifying recombinant C. caviae mnmA?

Researchers working with recombinant C. caviae mnmA should consider these challenges and solutions:

  • Potential [4Fe-4S] cluster:

    • If C. caviae mnmA contains a [4Fe-4S] cluster, it would be oxygen-sensitive

    • Expression and purification should be conducted under anaerobic conditions

    • Iron-sulfur cluster reconstitution may be necessary after purification

  • Solubility issues:

    • Bacterial sulfur transfer proteins often have solubility challenges

    • Consider fusion tags (MBP, SUMO) to improve solubility

    • Optimize buffer conditions to maintain stability

  • Activity preservation:

    • The catalytic mechanism involves reactive cysteine residues

    • Include reducing agents to prevent oxidation

    • Consider the inclusion of stabilizing agents during purification

  • Functional validation:

    • Confirm activity using in vitro assays with appropriate tRNA substrates

    • Verify proper folding through circular dichroism or limited proteolysis

    • Consider structural validation through analytical size exclusion chromatography

  • Co-factor considerations:

    • Ensure availability of essential co-factors (ATP, Mg²⁺)

    • If using the [4Fe-4S] mechanism hypothesis, include iron and sulfide sources

    • For the persulfide mechanism, include appropriate sulfur transfer components

The ongoing debate about the true catalytic mechanism (persulfide vs. [4Fe-4S]) presents a particular challenge, as different purification strategies would be optimal for each scenario.

How can researchers design experiments to resolve the persulfide versus [4Fe-4S] mechanism debate for mnmA?

Resolving this mechanistic debate requires careful experimental design:

  • Anaerobic purification and characterization:

    • Purify recombinant mnmA under strictly anaerobic conditions

    • Analyze for the presence of [4Fe-4S] clusters using UV-visible spectroscopy, electron paramagnetic resonance (EPR), and iron/sulfide quantification

    • Compare activity of aerobically versus anaerobically purified protein

  • Site-directed mutagenesis studies:

    • Target conserved cysteines potentially involved in persulfide formation or [4Fe-4S] cluster binding

    • Create variants with substitutions at these positions

    • Assess both in vitro activity and in vivo complementation

  • Definitive structural studies:

    • Obtain crystal structures of anaerobically purified mnmA

    • Use complementary techniques like Mössbauer spectroscopy to characterize [4Fe-4S] clusters

    • Consider cryo-electron microscopy for structural studies under native conditions

  • In vivo approaches:

    • Use radioactively labeled sulfur to track incorporation into tRNA

    • Conduct time-resolved studies to capture intermediates

    • Employ genetic approaches to manipulate potential [4Fe-4S] cluster assembly machinery

As noted in the literature: "In vivo studies that could definitively show the presence and involvement of an [Fe–S] cluster or a persulfide on MnmA, likely by the aid of radioactively labeled sulfur, would provide the most conclusive evidence to prove which of the proposed mechanisms is correct" .

What are the implications of mnmA research for understanding C. caviae pathogenesis?

Understanding mnmA function in C. caviae has several implications for pathogenesis research:

  • Translational fidelity during infection:

    • Proper tRNA modification is essential for accurate translation

    • This may be particularly important during host adaptation and stress responses

    • Misregulation could affect virulence factor expression

  • Developmental cycle regulation:

    • C. caviae undergoes a biphasic developmental cycle between elementary bodies (EBs) and reticulate bodies (RBs)

    • Phosphoproteomic analysis revealed stage-specific protein phosphorylation patterns

    • If mnmA is differentially regulated during this cycle, it could coordinate translation with developmental needs

  • Potential therapeutic targeting:

    • In T. gondii, knockout of TgMnmA attenuated virulence

    • Mice survived infection with TgMnmA-KO parasites

    • This suggests mnmA could be a potential drug target in related pathogens

  • Metabolic adaptation:

    • C. caviae has a compact genome with 1,009 ORFs and limited metabolic capabilities

    • Efficient translation through proper tRNA modification may be particularly important for optimal use of limited resources

Research on C. caviae mnmA may provide insights into fundamental aspects of chlamydial biology and potentially identify new approaches for therapeutic intervention.

How does studying C. caviae mnmA contribute to our broader understanding of tRNA modification across species?

Investigating C. caviae mnmA offers valuable comparative insights:

  • Evolutionary conservation:

    • The s²U34 modification is universally found in tRNA⁽ᴸʸˢ⁾, tRNA⁽ᴳˡᵘ⁾, and tRNA⁽ᴳˡⁿ⁾ across all domains of life

    • Comparing mnmA mechanisms across species reveals evolutionary adaptations

    • C. caviae represents an important intracellular bacterial pathogen lineage

  • Simplified systems:

    • Some organisms like B. subtilis lack intermediate persulfide carrier proteins

    • C. caviae, with its reduced genome, may reveal minimally essential components of the pathway

  • Specialized adaptations:

    • Intracellular pathogens face unique challenges in acquiring sulfur

    • The mnmA system may reveal adaptations for functioning in the host-pathogen interface

    • Variations in mechanism may reflect ecological niches

  • Integration with developmental biology:

    • The biphasic lifecycle of Chlamydia presents a unique context for studying tRNA modification

    • Potential coordination between developmental transitions and translational regulation

    • Stage-specific proteomics provides a framework for understanding temporal regulation

By studying C. caviae mnmA, researchers contribute to a more comprehensive understanding of tRNA modification systems across diverse organisms, potentially revealing both conserved principles and specialized adaptations.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.